Cooper Companies price to free cash flow COO

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 17.2×
10-year median: 36.6×
Against its 10-year history: 2nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 15.1× to 154×
Peer median: 19.8×

Cooper Companies' price to free cash flow is 17.2× as of Oct 23, 2026.

That is below its ten-year median of 36.6×, lower than on 98% of days in the last ten years.

Over that time it ranged from 15.1× in Sep 2026 to 154× in Aug 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 19.8×.

Price to free cash flow over time

median 36.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	17.2×	15.1×	38.0×
2025	37.3×	32.2×	67.7×
2024	64.0×	64.0×	154×
2023	87.2×	36.2×	87.2×
2022	36.2×	23.4×	40.0×
2021	39.5×	35.6×	108×
2020	101×	29.1×	106×
2019	37.4×	16.1×	37.4×
2018	25.9×	23.8×	32.0×
2017	22.8×	22.8×	29.7×
2016	23.9×	23.9×	50.9×
2015	43.8×	31.8×	44.5×
2014	36.4×	24.8×	40.1×
2013	25.4×	21.5×	27.7×
2012	20.6×	18.0×	21.1×
2011	18.1×	14.8×	21.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Cooper Companies' size, closest first, today.

Company	Price to free cash flow
COOCooper Companies	17.2×
ALGNAlign Technology	17.3×
GMEDGlobus Medical	14.5×
PENPenumbra	59.2×
PODDInsulet	35.2×
SOLVSolventum	n/m
MSAMSA Safety	19.8×
MMSIMerit Medical Systems	27.4×
HAEHaemonetics	18.5×
WSTWest Pharmaceutical Services	63.2×
VNTVontier	12.1×
Peer median	19.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Cooper Companies

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.